Skip to main content
Medicare now covers breakthrough technology to treat uncontrolled high blood pressure

Decision means millions of Americans have access to the Medtronic Symplicity SpyralTM renal denervation system

Learn more

Media Resources
Press releases
Oct 28, 2025
U.S. Centers for Medicare & Medicaid Services finalizes National Coverage Determination for the Medtronic Symplicity Spyral™ renal denervation (RDN) system

Symplicity blood pressure procedure is now covered for qualifying Medicare patients GALWAY, Ireland, Oct. 28, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare...

Oct 26, 2025
Three-year SPYRAL HTN-ON MED results show sustained, 18 mmHg office-based blood pressure reductions

Long-term data shows significant and sustained blood pressure reductions in both office-based and 24-hour ambulatory blood pressure, reinforcing the durability, safety and effectiveness of the...

Oct 9, 2025
Medtronic BrainSense™ Adaptive Deep Brain Stimulation named a 2025 TIME Best Inventions

Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that BrainSense™ Adaptive Deep Brain Stimulation (aDBS) – the world's first closed-loop DBS system for...

See more

In the news
Nov 25, 2024
She Lived with These Parkinson’s Symptoms for Over a Decade Before Diagnosis
Healthline
In January, Veronica Brown became one of the first patients in the world to be implanted with a Percept RC deep brain stimulation device.
Nov 21, 2024
Missed insulin doses cause complications. A new Medtronic app can detect when patients forget a dose.
Minnesota Star Tribune
The InPen app is part of the larger Smart MDI System, which includes a continuous glucose monitor and smart insulin pen.
Nov 20, 2024
Medtronic using AI to identify more TAVR patients in need
Cardiovascular Business
The company hopes to overcome longstanding health disparities and reach patients who may otherwise go untreated.

See more

Sign up for the latest updates
* Required Fields